BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues increased 7% to a record high $2.14 billion during the year ended December 31, 2007, compared to $1.99 billion for 2006. Reported net income equaled $183 million and diluted earnings per share equaled $0.75 during the year ended December 31, 2007, compared to net income of $289 million and diluted earnings per share of $1.19 during the prior year. Excluding special items, net earnings increased to $476 million and diluted earnings per share increased to $1.95 for the twelve months ended December 31, 2007, from net earnings of $423 million and diluted earnings per share of $1.74 in 2006.
